Comparative Proteomic Analysis Identifies Key Metabolic Regulators of Gemcitabine Resistance in Pancreatic Cancer-Reference-Cited by-同舟云学术

Comparative Proteomic Analysis Identifies Key Metabolic Regulators of Gemcitabine Resistance in Pancreatic Cancer

Published:2022-10 Issue:10 Volume:21 Page:100409
ISSN:1535-9476
Container-title:Molecular & Cellular Proteomics
language:en
Short-container-title:Molecular & Cellular Proteomics

Author:

Lin Qingxiang^ORCID,Shen Shichen,Qian Zhicheng,Rasam Sailee S.,Serratore Andrea^ORCID,Jusko William J.^ORCID,Kandel Eugene S.^ORCID,Qu Jun,Straubinger Robert M.^ORCID

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Analytical Chemistry

Reference111 articles.

1. Cancer statistics, 2021;Siegel;CA Cancer J Clin,2021

2. Estimated projection of US cancer incidence and death to 2040;Rahib;JAMA Netw. Open,2021

3. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Vaccaro;N. Engl. J. Med.,2011

4. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine;Von Hoff;N. Engl. J. Med.,2013

5. Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer;Hessmann;Gut,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of chemoresistance targets in doxorubicin-resistant lung adenocarcinoma cells using LC-MS/MS-based proteomics;Journal of Chemotherapy;2024-08-05

2. Gemcitabine elaidate and ONC201 combination therapy for inhibiting pancreatic cancer in a KRAS mutated syngeneic mouse model;Cell Death Discovery;2024-03-29

3. Fibroblast growth factor receptor 1 inhibition suppresses pancreatic cancer chemoresistance and chemotherapy-driven aggressiveness;Drug Resistance Updates;2024-03

4. Expression of fibroblast growth factor receptor 1 correlates inversely with the efficacy of single‐agent fibroblast growth factor receptor‐specific inhibitors in pancreatic cancer;British Journal of Pharmacology;2024-01-22

5. Highly Reproducible Quantitative Proteomics Analysis of Pancreatic Cancer Cells Reveals Proteome-Level Effects of a Novel Combination Drug Therapy That Induces Cancer Cell Death via Metabolic Remodeling and Activation of the Extrinsic Apoptosis Pathway;Journal of Proteome Research;2023-10-31